Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Toronto Stock Exchange:CRON
Globenewswire News
-
February 26, 2021
Lay off/Spin-off/Appointments
Olainfarm Group lays a strong foundation for sustainable development Riga Stock Exchange:OLF1R
Lay off/Spin-off/Appointments
BioSpace Movers & Shakers, Feb. 26
Lay off/Spin-off/Appointments
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Lay off/Spin-off/Appointments
Puma Biotechnology and Pierre Fabre Amend NERLYNX License Agreement to Include Greater China – FirstWord Pharma
Lay off/Spin-off/Appointments
Merck to Acquire Pandion Therapeutics
-
February 25, 2021
0
Lay off/Spin-off/Appointments
Allogene Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results...
Biospace News
-
February 25, 2021
0
Lay off/Spin-off/Appointments
MediWound Reports Fourth Quarter and Full-Year 2020 Financial Results
Biospace News
-
February 25, 2021
0
Lay off/Spin-off/Appointments
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics...
-
February 17, 2021
0
Lay off/Spin-off/Appointments
Sensorion Announces Third Gene Therapy Collaboration With Institut Pasteur Targeting Important...
-
February 16, 2021
0
1
2
3
...
59
Page 1 of 59
- Advertisement -
MOST POPULAR
Kaiku Health and Amgen roll out digital patient support for Multiple...
February 28, 2019
Acerus Provides Update On Avanafil Health Canada Submission
June 27, 2019
Amgen Invests $2.7 Billion in China’s BeiGene with Plans to Develop...
November 1, 2019
BioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3...
October 30, 2020
Load more
HOT NEWS
Others
Study: Regeneron’s garetosmab reduces bone lesions in patients with fibrodysplasia ossificans...
Others
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Others
ASH19: Sanofi’s C1s inhibitor sutimlimab increases haemoglobin levels in patients with...
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare...
